121das unternehmen konzernlagebericht konzernabschluss dr. ulrich moebius Head of Preclinical Development & Project Management dr. lisa rojkjaer Head of Clinical Development dr. harald watzka Head of Alliance Management dr. günter wellnhofer Head of Technical Operations dr. ralf ostendorp Head of Protein Sciences dr. margit urban Head of Target and Antibody Discovery dr. armin weidmann Head of Quality Assurance & Regulatory Affairs
